Highlights Fentanyl has meaningfully spread to U.S. illicit drug markets west of the Mississippi. 2019 and 2020 mortality records were identified from seven jurisdictions. Share of national synthetic narcotic mortality tripled from 2017 to 2019. Fentanyl is increasingly involved in fatal stimulant, heroin, and pill overdoses.

People in prison are particularly vulnerable to infectious disease due to close living conditions and the lack of protective equipment. As a result, public health professionals and prison administrators seek information to guide best practices and policy recommendations during the COVID-19 pandemic. Using latent profile analysis, we sought to characterize Texas prisons on levels of COVID-19 cases and deaths among incarcerated residents, and COVID-19 cases among prison staff. This observational study was a secondary data analysis of publicly available data from the Texas Department of Criminal Justice (TBDJ) collected from March 1, 2020, until July 24, 2020. This project was completed in collaboration with the COVID Prison Project. We identified relevant profiles from the data: a low-outbreak profile, a high-outbreak profile, and a high-death profile. Additionally, current prison population and level of employee staffing predicted membership in the high-outbreak and high-death profiles when compared with the low-outbreak profile. Housing persons at 85% of prison capacity was associated with lower risk of COVID-19 infection and death. Implementing this 85% standard as an absolute minimum should be prioritized at prisons across the USA.

No abstract

People in remission from substance use disorders (SUDs) have a history of using their own experience (also referred to as ''experiential knowledge'' or ''expertise'') to support those in or seeking SUD remission. In recent years, people with this experiential knowledge are being incorporated into research protocols to better guide research questions and inform the real-world uptake of SUD treatments and recovery supports. In these research contexts, however, those with research expertise and addiction rarely speak freely about these overlapping perspectives. The aim of this commentary is to increase awareness regarding the existence of this group (addiction researchers with addiction) and to explore the possibility that their expertise may help advance addiction science while helping to reduce stigma.

The health and well-being of students in recovery from substance use disorder is increasingly being recognized as a priority on college campuses. This scoping review maps the state of the existing literature evaluating collegiate recovery programming to highlight research gaps and inform policy. We conducted a systematic search of articles related to collegiate recovery programming published before August 2020. The 15 extracted study characteristics included publication type, study design, primary outcomes, reporting of behavioral addictions and mutual-help groups, sample demographic information, school size, ownership, and funding source. The PRISMA-guided search strategy identi ed 357 articles for abstract review; of 113 articles retained for full-text review, 54 studies were identi ed for nal inclusion. Primary outcomes were coded into four domains: clinical, lived experience, program characterization, and stigma. All but one of the articles were observational (57%) or qualitative (41%) research designs. Government or foundation grants funded only 11% of the studies. Findings suggest that collegiate recovery programs reduce risk of relapse, improve educational outcomes, and provide social support for students in recovery. The domains identi ed offer a framework for healthcare providers, college administrators, and researchers to understand and improve programs, thereby better serving this marginalized student group.